Save 59% now on BCBusiness Magazine for both digital and print.

Don't miss this amazing offer! 

Tech & Science

Oct 2, 2006
Big Pharma: Selling Sickness
Katherine Gordon

From Paxil and Prozac to Ritalin and Viagra, Big Pharma is a multibillion-dollar global business. With a court battle that may result in Canada allowing drug companies to target ads directly at ¬consumers, how much of 'selling sickness' are we willing to swallow?

Sep 1, 2006
BioLytical Labs: Star-studded Start-up
Jessica Werb

Where do you go for funding when you’re sitting on a biotech product that could help transform diagnostic procedures for one of the world’s most devastating viruses? When Richmond-based BioLytical Laboratories needed investors for its rapid HIV test, it looked...

Aug 1, 2006
Guide to Private Health Care in B.C.
Claudia Cornwall

As waiting lists at public hospitals proliferate, dozens of private clinics have emerged to satisfy the demands of ailing British Columbians seeking prompt care. Typically these clinics bill third-party insurers, such as WCB, or foreign visitors’ private health plans. However...

Aug 1, 2006
Health Care Privitization: Wealth Care
Claudia Cornwall

Tom Koch, 57, is a Vancouver-based ethicist and the author of a score of books about medical and journalistic issues of a moral nature. He describes himself as a democratic socialist. And when it comes to B.C.’s health-care system, he...

Aug 1, 2006
The Evolution of Addiction Treatment: Desperate For a Fix
Andrew Struthers

The evolution of addiction treatment began during the Vietnam War, with thousands of troops returning to the U.S. after being exposed to the abundance of cheap drugs in South East Asia. Today funding has been shaved off the treatment pillar leaving addiction treatment desperate for a fix.

Jul 1, 2006
B.C. Biotech Roundtable: Incubation Period
BCBusiness D.B.

For years, B.C.’s biotech sector has rested on the claim that it has spawned two local giants. But the boast is wearing thin. Does B.C. have what it takes to become the next Bay Area, or will we forever be the farm team for big pharmaceuticals eager to pluck the next great drug discovery and stay stuck in an incubation period? BCBusiness sat down with a round table to discuss.

Jul 1, 2006
Aspreva Pharmaceuticals: Biotech Breakthrough
David Jordan

The Dark Horse of the Year award goes to Aspreva Pharmaceuticals. This young biotech broke through the gate to not only crack the Top 100 public companies list just four years after its inception, but also claim bragging rights as the only biotech in B.C. to record a profit in 2005.

Nov 1, 2005
Industry Tax Credits: Biotech Booster
BCBusiness D.B.

Don’t knock scare tactics. They’ve worked well for B.C.’s so-called fragile biotech industry, whose boosters might say dire predictions are the best way to squeeze industry tax credits out of provincial government coffers.

Sep 1, 2005
Biotech Investing: Looking Fear in the Eye
Gregory Thomas

Sinking cash into biotech darlings such as QLT is not for the squeamish, but the payoff could be sweet. Paul Hastings lives in the tortured aftermath of great expectations. Two years before he left northern California to take the helm...

Copyright © Canada Wide Media Limited. All Rights Reserved
230, 4321 Still Creek Drive Burnaby, B.C. V5C 6S7, 604-299-7311
Use of this site constitutes acceptance of our Terms of Use & Privacy Policy